This is a Validated Antibody Database (VAD) review about mouse Dtna, based on 5 published articles (read how Labome selects the articles), using Dtna antibody in all methods. It is aimed to help Labome visitors find the most suited Dtna antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
Dtna synonym: 2210407P21Rik; DTN-A; Dtn; Gm19389; a-DB-1; adbn

Santa Cruz Biotechnology
mouse monoclonal (D-9)
  • immunohistochemistry - frozen section; human; 1:50; fig 1
Santa Cruz Biotechnology Dtna antibody (Santa Cruz, sc-271630) was used in immunohistochemistry - frozen section on human samples at 1:50 (fig 1). Int J Mol Sci (2022) ncbi
BD Biosciences
mouse monoclonal (23/Dystrobrevin)
  • immunohistochemistry; mouse; 1:200; loading ...; fig 1g
BD Biosciences Dtna antibody (BD Biosciences, 610766) was used in immunohistochemistry on mouse samples at 1:200 (fig 1g). Hum Mol Genet (2021) ncbi
mouse monoclonal (23/Dystrobrevin)
  • immunocytochemistry; mouse; fig 2
BD Biosciences Dtna antibody (BD Trunsd. Lab, 610766) was used in immunocytochemistry on mouse samples (fig 2). J Cell Sci (2016) ncbi
mouse monoclonal (23/Dystrobrevin)
  • immunohistochemistry - frozen section; mouse; 1:100; loading ...; fig s7
In order to study in vivo gene editing in dystrophic mouse muscle and muscle stem cells, BD Biosciences Dtna antibody (BD, 610766) was used in immunohistochemistry - frozen section on mouse samples at 1:100 (fig s7). Science (2016) ncbi
mouse monoclonal (23/Dystrobrevin)
  • immunohistochemistry - frozen section; mouse; 1:200; loading ...; fig s9
In order to present the role of in vivo genome editing in muscle function in a mouse model of Duchenne muscular dystrophy, BD Biosciences Dtna antibody (BD Biosciences, 23/Dystrobrevin) was used in immunohistochemistry - frozen section on mouse samples at 1:200 (fig s9). Science (2016) ncbi
Articles Reviewed
  1. Capitanio D, Moriggi M, Barbacini P, Torretta E, Moroni I, Blasevich F, et al. Molecular Fingerprint of BMD Patients Lacking a Portion in the Rod Domain of Dystrophin. Int J Mol Sci. 2022;23: pubmed publisher
  2. Wang H, Marrosu E, Brayson D, Wasala N, Johnson E, Scott C, et al. Proteomic analysis identifies key differences in the cardiac interactomes of dystrophin and micro-dystrophin. Hum Mol Genet. 2021;30:1321-1336 pubmed publisher
  3. Gingras J, Gawor M, Bernadzki K, Grady R, Hallock P, Glass D, et al. Α-Dystrobrevin-1 recruits Grb2 and α-catulin to organize neurotransmitter receptors at the neuromuscular junction. J Cell Sci. 2016;129:898-911 pubmed publisher
  4. Tabebordbar M, Zhu K, Cheng J, Chew W, Widrick J, Yan W, et al. In vivo gene editing in dystrophic mouse muscle and muscle stem cells. Science. 2016;351:407-411 pubmed publisher
  5. Nelson C, Hakim C, Ousterout D, Thakore P, Moreb E, Castellanos Rivera R, et al. In vivo genome editing improves muscle function in a mouse model of Duchenne muscular dystrophy. Science. 2016;351:403-7 pubmed publisher